A phase 1/2 study of once-daily oral VT-464 in patients with advanced androgen receptor (AR) positive triple negative (TNBC) or estrogen receptor (ER) positive breast cancer (BC) Meeting Abstract

  

Authors:	Gucalp, A.; Hudis, C.; Norton, L.; Patil, S.; Kurman, M. R.; Eisner, J. R.; Moore, W. R.; Traina, T. A.
Abstract Title:	A phase 1/2 study of once-daily oral VT-464 in patients with advanced androgen receptor (AR) positive triple negative (TNBC) or estrogen receptor (ER) positive breast cancer (BC)
Meeting Title:	38th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title:	Cancer Research
Volume:	76
Issue:	4 Suppl.
Meeting Dates:	2015 Dec 8-12
Meeting Location:	San Antonio, TX
ISSN:	0008-5472
Publisher:	American Association for Cancer Research
Date Published:	2016-02-15
Language:	English
ACCESSION:	WOS:000375622401233
DOI:	10.1158/1538-7445.sabcs15-ot2-01-03
PROVIDER:	wos
Notes:	Meeting Abstract: OT2-01-03 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/95134